Therapeutic Asset Ratings
184 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Botensilimab
Glioblastoma Multiforme
Northwestern University
P2
CCC
(53)
Botensilimab
Gliosarcoma
Northwestern University
P2
CCC
(53)
Botensilimab
Newly Diagnosed Glioblastoma
Northwestern University
P2
CCC
(53)
carbidopa
Back Injuries
Northwestern University
P2
CCC
(53)
carbidopa
Back Pain
Northwestern University
P2
CCC
(53)
carbidopa
Chronic Low-back Pain
Northwestern University
P2
CCC
(53)
carbidopa
Narcotic Use
Northwestern University
P2
CCC
(53)
carbidopa
Opioid Dependence
Northwestern University
P2
CCC
(53)
carbidopa
Opioid Use
Northwestern University
P2
CCC
(53)
carbidopa
Pain;Back Low;Chronic
Northwestern University
P2
CCC
(53)
Cyclophosphamide
Large B-Cell Lymphoma With IRF4 Rearrangement
Northwestern University
P2
CCC
(53)
FLUOROURACILUM
Advanced Lung Adenocarcinoma
Northwestern University
P2
CCC
(53)
Gadobutrol
Prostate Carcinoma
Northwestern University
P2
CCC
(53)
Hydroxychloroquine
Advanced Biliary Tract Carcinoma
Northwestern University
P2
CCC
(53)
Hydroxychloroquine
Advanced Colorectal Carcinoma
Northwestern University
P2
CCC
(53)
Hydroxychloroquine
Advanced Gastroesophageal Junction Adenocarcinoma
Northwestern University
P2
CCC
(53)
Hydroxychloroquine
Advanced Lung Adenocarcinoma
Northwestern University
P2
CCC
(53)
Hydroxychloroquine
Advanced Urothelial Carcinoma
Northwestern University
P2
CCC
(53)
Hydroxychloroquine
Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
Northwestern University
P2
CCC
(53)
Inno-206
Glioblastoma, Isocitric Dehydrogenase (IDH)-Wildtype
Northwestern University
P2
CCC
(53)
Inno-206
Gliosarcoma
Northwestern University
P2
CCC
(53)
Inno-206
Large B-Cell Lymphoma With IRF4 Rearrangement
Northwestern University
P2
CCC
(53)
Inno-206
Newly Diagnosed Glioblastoma
Northwestern University
P2
CCC
(53)
Inno-206
Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
Northwestern University
P2
CCC
(53)
Inno-206
Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
Northwestern University
P2
CCC
(53)
Showing 76 to 100 of 184 assets
Previous
Page 4 of 8
Next